Cadila Pharmaceuticals Ltd - Net Worth and Insider Trading

Cadila Pharmaceuticals Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cadila Pharmaceuticals Ltd owns 1 companies in total, including Novavax Inc (NVAX) .

Click here to see the complete history of Cadila Pharmaceuticals Ltd’s form 4 insider trades.

Insider Ownership Summary of Cadila Pharmaceuticals Ltd

Ticker	Comapny	Transaction Date	Type of Owner
NVAX	Novavax Inc	2009-03-31	10 percent owner

Cadila Pharmaceuticals Ltd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cadila Pharmaceuticals Ltd Ownership Network

Ownership Network List of Cadila Pharmaceuticals Ltd

No Data

Ownership Network Relation of Cadila Pharmaceuticals Ltd

Cadila Pharmaceuticals Ltd Owned Company Details

What does Novavax Inc do?

Who are the key executives at Novavax Inc?

Cadila Pharmaceuticals Ltd is the 10 percent owner of Novavax Inc. Other key executives at Novavax Inc include President & R&D Filip Dubovsky , President & R&D Gregory M Glenn , and EVP & Chief Strategy Officer Elaine O'hara .

Novavax Inc (NVAX) Insider Trades Summary

Over the past 18 months, Cadila Pharmaceuticals Ltd made no insider transaction in Novavax Inc (NVAX). Other recent insider transactions involving Novavax Inc (NVAX) include a net sale of 61,216 shares made by Filip Dubovsky , and a net sale of 15,000 shares made by James F Young .

In summary, during the past 3 months, insiders sold 7,500 shares of Novavax Inc (NVAX) in total and bought 0 shares, with a net sale of 7,500 shares. During the past 18 months, 76,216 shares of Novavax Inc (NVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 76,216 shares.

Novavax Inc (NVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Novavax Inc Insider Transactions

No Available Data

Cadila Pharmaceuticals Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Cadila Pharmaceuticals Ltd. You might contact Cadila Pharmaceuticals Ltd via mailing address: Sarkhej-dholka Road, Bhat, Ahmedabad K7 382 210.

Discussions on Cadila Pharmaceuticals Ltd

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.